CMS Finalizes Guidance on Medicare Part D Manufacturer Discount Program
FDA Law Blog: Biosimilars
DECEMBER 3, 2023
CMS will send the final manufacturer invoice for discount liabilities accrued by then on April 30, 2028. Its total expenditures for all specified drugs that are single source drugs or biologics for which payment may be made under Part B in 2021 represented less than 1.0% Final Guidance at 2.
104 
Let's personalize your content